{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T01:51:39Z","timestamp":1698112299241},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1992,2]]},"DOI":"10.1007\/bf01715350","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T00:30:51Z","timestamp":1119918651000},"page":"83-87","source":"Crossref","is-referenced-by-count":4,"title":["Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL)"],"prefix":"10.1007","volume":"64","author":[{"given":"M.","family":"Freund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wunsch-Zeddies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wysk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hiddemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"Hanauske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. -J.","family":"Schmoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Poliwoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01715350_CR1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/0277-5379(87)90123-4","volume":"23","author":"SA Ismail Al","year":"1987","unstructured":"Al Ismail SA, Whittaker JA, Gough J (1987) Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol 23: 1379\u20131384","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01715350_CR2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1","volume":"40","author":"JL Binet","year":"1977","unstructured":"Binet JL, Leporrier M, Dighiero G, et al. (1977) A clinical staging system for chronic lymphocytic leukemia. Prognostic significance. Cancer 40: 855\u2013864","journal-title":"Cancer"},{"key":"BF01715350_CR3","first-page":"19","volume":"13","author":"E Cavallin-Stahl","year":"1986","unstructured":"Cavallin-Stahl E, M\u00f6ller TR (1986) Prednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in Sweden. Semin Oncol 13: 19\u201322","journal-title":"Semin Oncol"},{"key":"BF01715350_CR4","unstructured":"Editorial (1988) Updated Kiel Classification. Lancet 1: 603\u2013613"},{"key":"BF01715350_CR5","first-page":"1209","volume":"71","author":"A Foss Abrahamsen","year":"1987","unstructured":"Foss Abrahamsen A, Lenner P, Hedenus M, Landys K, Noppa H (1987) Mitoxantrone in the treatment of patients with non-Hodgkin's lymphoma. Cancer Treat Rep 71: 1209\u20131212","journal-title":"Cancer Treat Rep"},{"issue":"Suppl 1","key":"BF01715350_CR6","first-page":"14","volume":"13","author":"DR Gandara","year":"1986","unstructured":"Gandara DR, Wold HG, Redmanod J, Kohler M, Reynolds R, Wong P, Forsythe J, Fisher K, Lewis B (1986) Prednimustine in refractory non-Hodgkin's lymphoma: a phase-II study of the Northern California Oncology Group. Semin Oncol 13 [Suppl 1]: 14\u201318","journal-title":"Semin Oncol"},{"key":"BF01715350_CR7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000225266","volume":"35","author":"L Hakansson","year":"1978","unstructured":"Hakansson L, K\u00f6nyves I, Lindberg LG, et al. (1978) Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031). Oncology 35: 103","journal-title":"Oncology"},{"key":"BF01715350_CR8","first-page":"345","volume":"10","author":"ME Heim","year":"1987","unstructured":"Heim ME, Fritze D, Ho AD, Mebes W, Abel U (1987) Phase-III-Studie zur Chemotherapie niedrig-maligner Non-Hodgkin-Lymphome: Vergleich einer Vincristin- mit einer Vindesin-Kombinations-Chemotherapie. Onkologie 10: 345\u2013348","journal-title":"Onkologie"},{"key":"BF01715350_CR9","first-page":"20","volume":"17","author":"W Hiddemann","year":"1990","unstructured":"Hiddemann W, Unterhalt M, Koch P, Nahler M, van de Loo J (1990) Treatment of low-grade non-Hodgkin's lymphoma by cytoreductive chemotherapy with prednimustine\/mitoxantrone followed by interferon \u03b1-2b maintenance: results of a clinical phase-II study. Semin Oncol 17: 20\u201323","journal-title":"Semin Oncol"},{"key":"BF01715350_CR10","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","volume":"311","author":"SJ Horning","year":"1984","unstructured":"Horning SJ, Rosenberg SA (1984) The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311: 1471\u20131475","journal-title":"N Engl J Med"},{"key":"BF01715350_CR11","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0277-5379(82)90092-X","volume":"14","author":"K Idestr\u00f6m","year":"1982","unstructured":"Idestr\u00f6m K, Kimby E, Bj\u00f6rkholm M, Mellstedt H, Enstedt L, Gahrton G, Johansson B, Killander D, Rob\u00e9rts K-H, Stalfelt A-M, Ud\u00e9n A-M, Wadman B, W\u00e4hlby S (1982) Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent highdose prednimustine versus chlorambucil\/prednisolone. Eur J Cancer 14: 1117\u20131123","journal-title":"Eur J Cancer"},{"key":"BF01715350_CR12","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1182\/blood.V75.10.1928.1928","volume":"75","author":"HM Kantarjian","year":"1990","unstructured":"Kantarjian HM, Alexanian R, Koller CA, Kurzrock R, Keating MJ (1990) Fludarabine therapy in macroglobulinemic lymphoma. Blood 75: 1928\u20131931","journal-title":"Blood"},{"key":"BF01715350_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Assoc 53: 457\u2013457","journal-title":"J Am Statist Assoc"},{"key":"BF01715350_CR14","first-page":"277","volume":"60","author":"JH Kaufman","year":"1976","unstructured":"Kaufman JH, Hanjura GL, Mittelman A, et al. (1976) Study of Leo-1031 (NSC-134087) in lymphocytic lymphoma and chronic lymphocytic leukemia. Cancer Treat Rep 60: 277","journal-title":"Cancer Treat Rep"},{"key":"BF01715350_CR15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood.V74.1.19.bloodjournal74119","volume":"74","author":"MJ Keating","year":"1989","unstructured":"Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB (1989) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 74: 19\u201325","journal-title":"Blood"},{"key":"BF01715350_CR16","first-page":"103","volume":"112","author":"P Klener","year":"1985","unstructured":"Klener P, Haber J (1985) Value of prednimustine in treating non-Hodgkin's lymphomas of favourable histological type. Folia Haematol (Leipz) 112: 103\u2013108","journal-title":"Folia Haematol (Leipz)"},{"key":"BF01715350_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00195368","volume":"6","author":"KE Landys","year":"1988","unstructured":"Landys KE (1988) Mitoxantrone in combination with prednimustine in treatment of unfavourable non-Hodgkin's lymphoma. Invest New Drugs 6: 105\u2013113","journal-title":"Invest New Drugs"},{"key":"BF01715350_CR18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207\u2013214","journal-title":"Cancer"},{"key":"BF01715350_CR19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.0954-6820.1980.tb09708.x","volume":"207","author":"J Pedersen-Bjergard","year":"1980","unstructured":"Pedersen-Bjergard J, Mork Hansen J, Geisler CH, et al. (1980) Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin's lymphomata and chronic lymphocytic leukemia previously treated with steroids and alkylating agents. Acta Med Scand 207: 215","journal-title":"Acta Med Scand"},{"key":"BF01715350_CR20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/1097-0142(19880201)61:3<441::AID-CNCR2820610306>3.0.CO;2-N","volume":"61","author":"WP Steward","year":"1988","unstructured":"Steward WP, Crowther D, McWilliam LJ, Jones JM, Deakin DP, Todd ID, Blackledge G, Wagstaff J, Scarffe JH, Harris M (1988) Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors. Cancer 61: 441\u2013447","journal-title":"Cancer"},{"key":"BF01715350_CR21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bjc.1991.253","volume":"64","author":"JS Whelan","year":"1991","unstructured":"Whelan JS, Davis CL, Rule S, Ranson M, Smith OP, Mehta AB, Catovsky D, Rohatiner AZ, Lister TA (1991) Fludarabine phosphate for the treatment of low-grade lymphoid malignancy. Br J Cancer 64: 120\u2013123","journal-title":"Br J Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01715350.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01715350\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01715350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:14:29Z","timestamp":1586304869000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01715350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["BF01715350"],"URL":"https:\/\/doi.org\/10.1007\/bf01715350","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,2]]}}}